Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKR1C3 | P42330 | 12/20 | 1.00 |
| ▸ | AKR1C2 | P52895 | 12/20 | 1.00 |
| ▸ | PTGS1 | P23219 | 3/20 | 1.00 |
| ▸ | AKR1C1 | Q04828 | 2/20 | 1.00 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.65 |
| ▸ | TSHR | P16473 | 2/20 | 0.65 |
| ▸ | CDC42 | P60953 | 1/20 | 0.65 |
| ▸ | RAC1 | P63000 | 1/20 | 0.65 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.65 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 0.65 |
| ▸ | AKR1B10 | O60218 | 1/20 | 0.54 |
| ▸ | AKR1C4 | P17516 | 1/20 | 0.54 |
| ▸ | ABCB11 | O95342 | 1/20 | 0.54 |
| ▸ | LMNA | P02545 | 1/20 | 0.54 |
| ▸ | MAPT | P10636 | 1/20 | 0.54 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.54 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.52 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.50 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24991971 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL505820 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL506301 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL32670176 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL32670173 | 1.00 | AKR1C3 (1.00) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL506524 | 0.88 | AKR1C3 (0.78) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL11157532 | 0.88 | AKR1C3 (0.78) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL11161413 | 0.88 | AKR1C3 (0.78) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL9560269 | 0.88 | AKR1C3 (0.78) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 | |
| SCHEMBL15535590 | 0.86 | AKR1C3 (0.76) | AKR1C3AKR1C2PTGS1AKR1C1PTGS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230039244-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | UNIV PENNSYLVANIA (US) | 2023-02-09 | — | — | US | claimed |
| US-11459295-B2 | 2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-10-04 | — | — | US | claimed |
| US-20180305305-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2018-10-25 | — | — | US | claimed |
| WO-2024030627-A1 | INHIBITORS OF AKR1C3 AND METHODS OF USE | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA (US) | 2024-02-08 | — | — | WO | disclosed |
| US-20230039244-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | UNIV PENNSYLVANIA (US) | 2023-02-09 | — | — | US | disclosed |
| US-20230039244-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | UNIV PENNSYLVANIA (US) | 2023-02-09 | — | — | US | disclosed |
| US-11459295-B2 | 2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2022-10-04 | — | — | US | disclosed |
| WO-2022089612-A1 | USE OF URIDINE DERIVATIVE IN PREPARATION OF MEDICAMENT | 上海岸阔医药科技有限公司 | 2022-05-05 | — | — | WO | disclosed |
| WO-2022089614-A1 | APPLICATION OF THYMIDINE DERIVATIVE IN PREPARATION OF DRUGS | 上海岸阔医药科技有限公司 | 2022-05-05 | — | — | WO | disclosed |
| US-20180305305-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA | 2018-10-25 | — | — | US | disclosed |
| WO-2017070448-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-04-27 | — | — | WO | disclosed |
| WO-2017070448-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2017-04-27 | — | — | WO | disclosed |
| WO-2010129505-A2 | NAPTHYLENE INHIBITORS OF CYCLOOXYGENASE | AUSPEX PHARMACEUTICALS, INC. (US) | 2010-11-11 | — | — | WO | disclosed |
| US-6365398-B1 | REACTING RACEMIC CARBOXYLIC ACID ESTER WITH RACEMIC ALCOHOL IN PRESENCE OF A CARBOXYL ESTER HYDROLASE | BASF AKTIENGESELLSCHAFT (DE) | 2002-04-02 | — | — | US | disclosed |
| EP-0048136-B1 | PROCESS FOR PREPARING ALPHA-AROMATIC GROUP SUBSTITUTED ALKANOIC ACIDS OR ESTERS THEREOF | SYNTEX PHARMACEUTICALS INTERNATIONAL LIMITED (BM) | 1986-06-11 | — | — | EP | disclosed |
| US-4420639-A | Aromatic compounds | BEECHAM GROUP LIMITED (GB) | 1983-12-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11459295-B2 | 2-beta-naphthyl-acetic acid analogs as AKR1C3 inhibitors and methods of using same | AKR1C3, AKR1C2, AKR1A1 | AKR1C3 1/4885AKR1C2 2/4885PTGS1 408/4885 |
| US-20180305305-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | AKR1C3, AKR1C2, AKR1A1 | AKR1C3 1/4885AKR1C2 2/4885PTGS1 408/4885 |
| US-20230039244-A1 | 2-BETA-NAPHTHYL-ACETIC ACID ANALOGS AS AKR1C3 INHIBITORS AND METHODS OF USING SAME | AKR1C3, AKR1C2, AKR1A1 | AKR1C3 1/4885AKR1C2 2/4885PTGS1 341/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.